AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 125 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,082,000 | +164.5% | 101,632 | +24.2% | 0.01% | +200.0% |
| Q3 2019 | $2,299,000 | +40.8% | 81,832 | +89.7% | 0.00% | 0.0% |
| Q2 2019 | $1,633,000 | +4.1% | 43,129 | +7.3% | 0.00% | 0.0% |
| Q1 2019 | $1,568,000 | +79.0% | 40,190 | -2.2% | 0.00% | +100.0% |
| Q4 2018 | $876,000 | -48.3% | 41,090 | -4.0% | 0.00% | -50.0% |
| Q3 2018 | $1,694,000 | +0.7% | 42,790 | -2.9% | 0.00% | 0.0% |
| Q2 2018 | $1,683,000 | +422.7% | 44,057 | +311.6% | 0.00% | – |
| Q1 2018 | $322,000 | – | 10,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |